Doha

Doha has rapidly emerged as a premier global life sciences hub, strategically positioning itself at the intersection of precision medicine and digital transformation.

Under the framework of Qatar National Vision 2030, the city’s ecosystem is anchored by Sidra Medicine and Hamad Medical Corporation, which lead the region in genomic research and advanced clinical trials.

Doha is best known for its world-class biomedical research infrastructure, particularly through the Qatar Genome Programme, which integrates high-throughput sequencing with personalized healthcare delivery.

The biotechnology and pharmaceutical sectors are fueled by the Qatar Science & Technology Park (QSTP), a specialized free zone that fosters biotech startups and international R&D collaborations.

Academic research excellence is driven by Hamad Bin Khalifa University (HBKU) and Weill Cornell Medicine-Qatar, creating a robust pipeline of scientific talent and healthcare innovation.

The ecosystem also prioritizes medical device development, leveraging artificial intelligence (AI) and machine learning to enhance diagnostic accuracy and patient outcomes.

Through the QRDI Council, Doha provides significant funding for translational medicine, bridging the gap between laboratory discovery and commercialization.

This integrated approach ensures that Doha remains a competitive destination for venture capital and global life sciences partnerships.